Abstract: A grease-enclosed bearing having enclosed therein a grease composition containing a thickener which is a diurea compound represented by Formula (1) or a mixture thereof, and a base oil containing an alkyldiphenyl ether oil and a poly-?-olefin oil as an optional component in a mass ratio of alkyldiphenyl ether oil:poly-?-olefin oil=from 40:60 to 100:0: R1-NHCONH—R2-NHCONH—R3??Formula (1) wherein at least either one of R1 and R3 is an aromatic hydrocarbon group having a carbon number of 6 to 12, the other one is an aromatic hydrocarbon group having a carbon number of 6 to 12 or an aliphatic hydrocarbon group having a carbon number of 6 to 20, and R2 is an aromatic hydrocarbon group having a carbon number of 6 to 15.

Abstract: The present invention refers to analog compounds of peptides having the amino acid sequences SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3 or SEQ ID NO: 4, including analgesic peptides derived from snakes of species such as Crotalus durissus terrificus; their uses in the treatment, diagnosis and prevention of painful conditions or mediated by opioid receptors, their pharmaceutical compositions and their methods of preparation and purification, including their uses in the identification of analgesic compounds.

Abstract: Disclosed herein is an electrolytic erosion preventing insulated rolling bearing and a manufacturing method thereof. In one embodiment, the electrolytic erosion preventing insulated rolling bearing includes an insulating coating being a ceramic coating layer including alumina as the main component and 0.01 to 0.2 percent by weight titanium oxide with the alumina having a particle size ranging from 10 to 50 ?m and average particle size ranging from 15 to 25 ?m.

Abstract: The present invention refers to uses of crotamine and compositions containing it, based on its characteristic of interaction with genetic material. Under submicromolar quantities, the polypeptide is no longer toxic, presenting the characteristics properties of cell penetration, transport of molecules to the surface, cytoplasm or cell nucleus and particularly, selective cell penetration. The invention also refers to compositions comprising a pharmaceutically effective concentration of crotamine and its use for the treatment of diseases and dysfunctions, based on its characteristics of interaction with genetic material, such as DNA and RNA, and cell selectivity.

Abstract: In order to ensure high levels of insulation performance, and low cost, and have an excellent external appearance, as a ceramic constituting an insulating coating 6 being a ceramic coating layer, one with alumina as its main component, and in which the content of titanium oxide is limited to 0.01 to 0.2 percent by weight is used. Moreover, a particle size of ceramic forming the coating layer is 10 to 50 ?m, and average particle size is 15 to 25 ?m. By limiting the content of titanium oxide, the insulating coating 6 can be made thin, and by limiting the particle size the film thickness accuracy can be improved, thus simplifying finishing. Moreover, by mixing of titanium oxide, deterioration of the external appearance after sealing can be prevented. As a result, the above problem is solved.

Abstract: The present invention refers to analog compounds of peptides having the amino acid sequences SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3 or SEQ ID NO: 4, including analgesic peptides derived from snakes of species such as Crotalus durissus terrificus; their uses in the treatment, diagnosis and prevention of painful conditions or mediated by opioid receptors, their pharmaceutical compositions and their methods of preparation and purification, including their uses in the identification of analgesic compounds.

Abstract: The present invention refers to uses of crotamine and compositions containing it, based on its characteristic of interaction with genetic material. Under submicromolar quantities, the polypeptide is no longer toxic, presenting the characteristics properties of cell penetration, transport of molecules to the surface, cytoplasm or cell nucleus and particularly, selective cell penetration. The invention also refers to compositions comprising a pharmaceutically effective concentration of crotamine and its use for the treatment of diseases and dysfunctions, based on its characteristics of interaction with genetic material, such as DNA and RNA, and cell selectivity.

Abstract: Provided are 1,25-dihydroxy-2-methylvitamin D3 derivatives expressed by the general formula (I), [wherein each of R1 and R2 is independently a hydrogen atom or a tri(C1 to C7 alkyl)silyl group; herein configurations of asymmetric carbons at the 1-, 2- and 3-positions are each independently ?-configuration or ?-configuration] and their production methods. The compound is useful as a treating agent for osteoporosis, rickets, hyperthyroidism, etc.

Abstract: A four-row tapered roller bearing is incorporated in the clearance between the inner surface of a housing and the outer surface of a rolling roller. A pair of supporting members supporting sensor devices are fitted in and supported by a part of the inner surface of the housing in such a manner that they are opposed to the ends of outer rings of the four-row tapered roller bearing disposed close to the both axial ends thereof. The sensor devices each comprise a distortion gauge as a detecting portion and a first coil for transmitting as a wireless signal a signal obtained by processing an output signal outputted from the distortion gauge. A second coil for receiving the wireless signal transmitted by the first coil is retained on a part of a member other than the supporting members.

Abstract: An object of the present invention is to synthesize a novel vitamin D3 derivative having a substituent at the 2?-position. The present invention provides vitamin D derivatives represented by-Formula (I): wherein R1 represents a saturated aliphatic C1-15hydrocarbon group optionally substituted with 1 to 3 hydroxy or protected hydroxy groups; and R2 represents a saturated aliphatic C1-10hydrocarbon group optionally substituted with one or more substituents, which may be the same or different and which are selected from the group consisting of a hydroxy group, a halogen atom, a cyano group, a lower alkoxy group, an amino group and an acylamino group, provided that when R2 represents a saturated aliphatic C1hydrocarbon group, R2 is substituted with at least one substituent.

Abstract: A four-row tapered roller bearing is incorporated in the clearance between the inner surface of a housing and the outer surface of a rolling roller. A pair of supporting members supporting sensor devices are fitted in and supported by a part of the inner surface of the housing in such a manner that they are opposed to the ends of outer rings of the four-row tapered roller bearing disposed close to the both axial ends thereof. The sensor devices each comprise a distortion gauge as a detecting portion and a first coil for transmitting as a wireless signal a signal obtained by processing an output signal outputted from the distortion gauge. A second coil for receiving the wireless signal transmitted by the first coil is retained on a part of a member other than the supporting members.

Abstract: The present invention provides a peptide represented by the amino acid sequence formula (A): H-X1-X2-X3-X4-Gly-X6-X7-Asp-Gln-R  (A) wherein: each of X1 and X3 independently represents Arg or Lys, each of X2, X4 and X6 independently represents Ile or Leu, and X7 represents Phe, Tyr or Trp; and R represents -NH2, -Leu-NH2, -Leu-Ser-NH2, -Leu-Ser-Lys-NH2, -Leu-Ser-Arg-NH2, -Leu-Ser-Lys-Leu-NH2, or -Leu-Ser-Arg-Leu-NH2; and a salt thereof. (In the above, Gly stands for a glycine residue, Asp stands for an aspartic acid residue, Gln stands for a glutamine residue, Arg stands for an arginine residue, Lys stands for a lysine residue, Ile stands for an isoleucine residue, Leu stands for a leucine residue, Phe stands for a phenylalanine residue, Tyr stands for a tyrosine residue, Trp stands for a tryptophan residue, and Ser stands for a serine residue.) The peptide acts on glutamate receptors and is expected to be useful in the treatment of cerebral nerve diseases associated with glutamic acid.

Abstract: A roller bearing comprising an outer ring having an outer ring raceway, an inner ring having an inner ring raceway, the inner peripheral surface at the end portion of the outer ring and/or the outer peripheral surface at the end portion of the inner ring formed with a flange portion, and a plurality of rollers having a rolling surface in contact with the outer and inner ring raceways, a sliding contact face in sliding contact with the inner face of the flange portion, and a chamfered portion provided between the sliding contact face and the rolling face, the sliding contact face smoothly connected to the chamfered portion in a curved surface the radius of curvature of which is at least 0.08 mm, and provided that the center line average height roughness of the sliding contact surface is .delta..sub.1 while the center line average height roughness of the inner face in contact with the sliding surface is .delta..sub.2, the composite roughness represented by the formula (.delta..sub.1.sup.2 +.delta..sub.2.sup.2).

Abstract: An apparatus is provided for use in printing systems wherein regions of rupturable capsules of a layer of capsules adsorbed on an imaging sheet are ruptured to release chromogenic materials that react to developer and print an image on a sheet. The apparatus has a container storing the capsules. A separately prepared sheet of plain paper is fed into the apparatus where the capsules are adsorbed thereon, forming an imaging sheet. Then an image is outputted from the apparatus through exposure process and development process. As a consequence, the user do not directly touch capsules which are vulnerable to friction and rubs, and this facilitates the handling of the imaging sheet.

Abstract: An apparatus is provided for use in color printing systems wherein an image is projected by a plurality of monochrome pictures corresponding to the pictures separated into three primary colors onto an imaging sheet which contains in layers pressure rupturable capsules, each encapsulating a dye and a photosensitive composition. The plural monochrome pictures are made by a laser scanner unit on the surface of a photosensitive drum according to image information and are transferred from the surface of the photosensitive drum to a transparent film. The transparent film is moved between a light source unit and a projection lens unit to project the plural monochrome pictures onto the imaging sheet.